PIPA522818
Adenovirus Type 3 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA522818-Each-of-1 | In Stock | ₹ 46,591.50 |
PIPA522818 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,591.50
GST (18%): ₹ 8,386.47
Total Price: ₹ 54,977.97
Antigen
Adenovirus Type 3
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
Adeno Virus; Adeno Virus 3; AdV; AdV-3; HADV; HADV-3
Immunogen
Synthetic peptide within residues 250-270 of the fiber knob protein of Ad 3.
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Adenoviruses are DNA viruses generally widespread in nature that are frequently the cause of acute upper respiratory tract infections (i.e
- common colds)
- 49 human adenovirus serotypes have been discovered and divided into six subgroups, A to E, based on observation
- They are an important cause of respiratory illness, conjunctivitis, gastroenteritis, and have more recently been recognized as a potential cause of sexually transmitted diseases
- Several types have oncogenic potential though most cause self-limiting febrile illnesses characterized by inflammation of conjunctivae and the respiratory tract
- The virus can be isolated from the majority of tonsils/adenoids surgically removed, indicating latent infections
- It is not known how long the virus can persist in the body, or whether it is capable of reactivation after long periods
- In patients experiencing immunosuppression (e.g
- AIDS) it can be reactivated, causing disease
- Adenovirus vectors, particularly those based on Ad5, have shown great promise for the development of gene therapy protocols and have been used for clinical purpose.